MarketCap
Facebook
X
TelegramQuarterly report 2026-Q2
added 06-01-2026
Agilent Technologies Total Inventories 2011-2026 | A
Annual Total Inventories Agilent Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.02 B | 972 M | 1.03 B | 1.04 B | 830 M | 720 M | 679 M | 628 M | 575 M | 533 M | 541 M | 1.07 B | 1.07 B | 1.01 B | 898 M | 716 M | 552 M | 646 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.07 B | 533 M | 808 M |
Quarterly Total Inventories Agilent Technologies
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.09 B | 1.06 B | 1.06 B | 1.02 B | 1.01 B | 997 M | 997 M | 972 M | - | 1.03 B | - | 1.07 B | 1.1 B | 1.1 B | 879 M | 1.04 B | - | 937 M | 755 M | 830 M | 818 M | 830 M | 706 M | 720 M | 720 M | 750 M | 653 M | 679 M | 679 M | 679 M | 608 M | 628 M | 628 M | 628 M | 551 M | 575 M | 575 M | 575 M | 554 M | 533 M | 533 M | 533 M | 560 M | 541 M | 541 M | 541 M | 1.09 B | 574 M | 574 M | 574 M | 1.04 B | 1.07 B | 1.07 B | 1.07 B | 937 M | 1.01 B | 1.01 B | 1.01 B | 797 M | 898 M | 898 M | 898 M | 688 M | 546 M | 548 M | 571 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.1 B | 533 M | 796 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
189 M | $ 205.36 | 0.42 % | $ 22.8 B | USA |
 |
Co-Diagnostics
CODX
|
992 K | $ 4.24 | -5.89 % | $ 5.64 M | USA |
 |
Castle Biosciences
CSTL
|
10.3 M | $ 21.21 | 0.62 % | $ 615 M | USA |
 |
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
2.85 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.3 M | $ 150.56 | -0.83 % | $ 11.8 B |  Irlanda |
 |
Illumina
ILMN
|
564 M | $ 165.51 | 3.42 % | $ 25.7 B | USA |
 |
Guardant Health
GH
|
85.9 M | $ 131.53 | 1.08 % | $ 16.5 B | USA |
 |
CareDx, Inc
CDNA
|
26.7 M | $ 23.02 | 1.16 % | $ 1.23 B | USA |
 |
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | USA |
 |
Interpace Biosciences
IDXG
|
1.11 M | $ 1.79 | 2.87 % | $ 7.92 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M |  China |
 |
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
64.7 M | $ 101.92 | 1.94 % | $ 6.88 B | USA |
 |
Charles River Laboratories International
CRL
|
299 M | $ 190.17 | 0.09 % | $ 9.43 B | USA |
 |
Pacific Biosciences of California
PACB
|
49.3 M | $ 1.4 | 1.82 % | $ 420 M | USA |
 |
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
387 M | $ 1 142.15 | -1.79 % | $ 23.5 B |  Schweiz |
 |
NeoGenomics
NEO
|
28.6 M | $ 11.7 | 2.27 % | $ 1.5 B | USA |
 |
Myriad Genetics
MYGN
|
30.6 M | $ 4.61 | 1.43 % | $ 427 M | USA |
 |
Natera
NTRA
|
68.4 M | $ 219.39 | -1.54 % | $ 30 B | USA |
 |
Senseonics Holdings
SENS
|
6.7 M | $ 7.31 | -1.62 % | $ 305 M | USA |
 |
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
15 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
1.49 M | $ 2.03 | -1.02 % | $ 4.66 M | USA |
 |
Twist Bioscience Corporation
TWST
|
28.3 M | $ 69.19 | -1.24 % | $ 4.14 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
535 M | $ 273.61 | 0.89 % | $ 22.8 B | USA |
 |
Thermo Fisher Scientific
TMO
|
5.42 B | $ 487.41 | -1.4 % | $ 184 B | USA |
 |
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
191 M | $ 9.27 | -0.22 % | $ 2.01 B | USA |
 |
Waters Corporation
WAT
|
572 M | $ 368.52 | -0.66 % | $ 21.9 B | USA |